Canadian IPOs All But Vanished in 2022: Here’s How 3 New Listings Did

A $9.2 billion Canadian IPO market in 2021 slumped to record lows in 2022. Two IPOs produced market-beating returns. Here how Bausch + Lomb Corp stock and others performed.

| More on:

Initial public offerings (IPOs) are spectacular events in the Canadian stock market. They present investors with more opportunities to choose from, provide more chances of hitting jackpot-type returns, and offer more options to improve portfolio diversification. However, following the record-breaking year 2021, when Canadian IPOs raised $10.2 billion from the public market, the IPO market abruptly cooled off to record lows in 2022.

About 77 new companies graced Canadian exchanges in 2021. They raised a record $9.2 billion. The number excludes Special Purpose Acquisition Companies (SPACs) and capital pool funds. The market turned south in 2022. The number of new Canadian IPOs declined to 42 companies in 2022, raising a paltry $1.3 billion.

Why Canadian IPOs vanished in 2022

The Canadian and global investment market environment abruptly changed between 2021 and 2022.

Investor spirits were high and optimism reigned in the markets in 2021. Easy money flooded the capital markets, as interest rates touched record lows. The TSX soared by 21% for the year. It was a great time for companies to raise new capital in the market by going public. It was the best time for early investors to sell stocks and exit long-held private investments to new shareholders through IPOs.

Moods changed in 2022. Investors freaked out, as “transitory” inflation threatened to stay. Interest rates rose at a record pace, and markets tumbled. Growth stocks with frothy valuations and weak fundamentals got clobbered.

Very few investors, IPO sponsors, founders, and company executives were willing to bring new companies onto exchanges when stock prices were coming down. Not only would their compensation be too low, but the risk of losing money was also just too high.

However, not all 2022 IPOs lost investors’ money. Here’s how the three largest Canadian news listings performed during their first calendar year trading on the public stock market.

Kiwetinohk Energy

Natural gas producer and fast-growing renewable energy company Kiwetinohk Energy (TSX:KEC) was listed on the TSX and started trading on January 14, 2022. The company chose a brilliant time to go public. Rapid production growth and soaring oil and natural gas prices gave new IPO investors great reasons to invest in the ambitious natural gas and green energy firm.

At the time of going public, management guided for 2022 production of 13,000-15,000 barrels of oil equivalent per day (boe/d). Full-year 2022 production averaged 17,900 boe/d. The company overdelivered on its production promises, and surging oil and natural gas prices amplified the financial impact.

Revenue and funds flow exceeded prior market estimates. KEC stock price closed 16.6% higher for 2022.

Ivanhoe Electric

Technology and mineral exploration company Ivanhoe Electric (TSX:IE) went public in a private equity-backed, dual-listed IPO in June 2022 that raised US$169 million. Shares also trade on the NYSE.

Ivanhoe Electric’s most attractive asset is its disruptive Typhoon, a geophysical survey technology obtained from its parent company I-Pulse. The Typhoon technology can cost effectively detect copper, gold, silver, and nickel, water, and oil at depths deeper than other conventional technologies’ given ranges, or where a cover hides deposits, and across vast tracts of land.

The company uses its survey technology exclusively, however, a recent US$126.4 million investment deal with Saudi Arabia’s mining giant Ma’aden will extend Typhoon access to a third party for the first time.

Ivanhoe Electric stock rose 16.9% during 2022. IE stock is up 26.1% since its IPO and trades 8.4% higher so far this year.

Bausch + Lomb

Bausch + Lomb (TSX:BLCO) is an $8.1 billion company that spun off from parent company Bausch Health in a dual-listed IPO on the TSX and the New York Stock Exchange in May 2022. The company is a global eye healthcare giant, with significant clout in the populous markets of India and China.

The parent company Bausch Health retains a controlling stake in the spin-off and donated its Chief Executive Officer Joseph C. Papa to the newly listed company. Papa is set to leave Bausch + Lomb in March this year.

Reported net earnings significantly declined in 2022, even as revenue remained stable. Operating costs and interest costs have increased as the company became a standalone business weaned from its parent.

BLCO stock lost 17.9% of its value post-IPO in 2022. That said, shares are up 7.5% year to date.

Fool contributor Brian Paradza has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

woman stares at chocolate layer cake
Dividend Stocks

Why Smart Investors Are Eyeing These 3 Canadian Stocks Right Now

These three TSX picks offer real assets and clear catalysts, without needing a perfect market to work.

Read more »

Income and growth financial chart
Stocks for Beginners

This Stock, Up Over 306% in 10 Years, Looks Like a Genius Buy Right Now

Brookfield stock appears to be a genius buy for long-term investors, particularly on market dips.

Read more »

Person holds banknotes of Canadian dollars
Retirement

How to Build a Retirement Portfolio That Generates $2,000 a Month

Are you wondering how you could earn $2,000 of passive income for retirement? These two different approaches could get you…

Read more »

Couple working on laptops at home and fist bumping
Dividend Stocks

The Canadian Stocks I’d Prioritize if I Had $5,000 to Invest Right Now

These two TSX stocks offer a good combo of growth and stable income, making them excellent picks to consider for…

Read more »

dividend stocks are a good way to earn passive income
Dividend Stocks

Today’s Perfect TFSA Stock: 6% Monthly Income

SmartCentres REIT stands out as the perfect TFSA stock for Canadians seeking reliable monthly income, and long‑term stability.

Read more »

A modern office building detail
Dividend Stocks

2 Canadian REITs That Look Worth Buying Right Now

SmartCentres REIT (TSX:SRU.UN) and another yield-rich, passive-income play are fit for Canadian value seekers.

Read more »

man looks surprised at investment growth
Investing

3 Canadian Stocks That Look Undervalued and Worth Buying Right Now

These high-quality Canadian stocks still look undervalued and are well-positioned to deliver notable growth in the future.

Read more »

dividends grow over time
Investing

3 Canadian Growth Stocks Worth Adding to a TFSA This Year

Three Canadian growth stocks are valuable additions to the TFSA for investors prioritizing capital gains over dividend income in 2026.

Read more »